Home › Funds › MFS Investment Management › BVS
MFS Investment Management position in BVS
BIOVENTUS INC · Health Care
Latest position (Q4 2023)55.24K sh
Reported value held$291.10K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 17.47K | $253.00K | New |
| Q2 2022 | 148.13K | $1.01M | Add |
| Q3 2022 | 146.80K | $1.03M | Reduce |
| Q4 2022 | 149.97K | $391.42K | Add |
| Q1 2023 | 145.85K | $156.06K | Reduce |
| Q2 2023 | 59.17K | $170.99K | Reduce |
| Q3 2023 | 56.98K | $188.04K | Reduce |
| Q4 2023 | 55.24K | $291.10K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BVS
- BlackRock Inc 3.44M sh · $32.44M · Q2 2026
- Vanguard Group 2.98M sh · $22.21M · Q4 2025
- Royce & Associates 1.83M sh · $17.31M · Q2 2026
- Geode Capital Management 1.37M sh · $12.89M · Q2 2026
- Wellington Management Group 748.36K sh · $7.06M · Q2 2026
- Renaissance Technologies 736.00K sh · $6.95M · Q2 2026
- Goldman Sachs Group 652.37K sh · $6.16M · Q2 2026
- Fidelity Management & Research (FMR) 452.85K sh · $4.27M · Q2 2026
- Northern Trust Corp 443.82K sh · $4.19M · Q2 2026
- Prudential Financial 394.52K sh · $3.72M · Q2 2026
- Charles Schwab Investment Management 391.86K sh · $3.70M · Q2 2026
- AQR Capital Management 326.12K sh · $3.08M · Q2 2026